1. JAK inhibitors potentially reduce artery damage in RA and psoriatic arthritis patients.
2. Study involved 48 adults over 12 months.
3. Average carotid intima-media thickness decreased significantly.
4. Systemic inflammation and median CRP levels improved.
5. Lp(a) levels decreased but remained a significant predictor of plaque presence.
6. Low ABI increased risk of acute cardiovascular events.
7. Patients still at risk despite treatment, highlighting need for monitoring.

Source: Journal of Clinical Medicine